Buy These 2 Biotech Stocks on the Dip After an FDA Delay
Don't worry about the FDA's clinical hold on gene-editing therapy CTX001. Vertex and CRISPR Therapeutics stocks will bounce back.
from Yahoo Finance https://ift.tt/2JrcvU2
Don't worry about the FDA's clinical hold on gene-editing therapy CTX001. Vertex and CRISPR Therapeutics stocks will bounce back.
from Yahoo Finance https://ift.tt/2JrcvU2
Comments
Post a Comment